UHRF1 and pancreatic neoplasm: Our data suggest that the Keap1–Nrf2 pathway is activated in pancreatic cancer cell lines through UHRF1‐mediated suppression of Keap1 protein levels, with Keap1 promoter methylation potentially contributing to this.